Head of Thoracic Cancer, Global Marketing, Oncology Business Unit
Scorpion Therapeutics, Boston, Massachusetts, us, 02298
Role Summary
Head of Thoracic Cancer, Global Marketing, Oncology Business Unit. As a member of Takeda Oncology, contribute to a bold vision to cure cancer. Report to the Head of Global Marketing Oncology Products, Pipeline and Strategy and collaborate with a cross-functional, global team to drive an asset in the NSCLC space. Responsibilities
Shape and influence global asset strategy through collaboration with R&D and Global Product Leaders, driving the Clinical Development Program and other asset components. Partner with senior leadership across functions to accelerate asset development and deliver on KPI’s and revenue targets. Lead execution of the global asset strategy, ensuring commercial launch readiness and alignment with Oncology objectives. Drive development of the NSCLC Disease Area Strategy and Brand Plan, including branding, financial planning, forecasting, and lifecycle management. Inspire and lead a team of Global Brand Leads to achieve brand success and differentiation. Set strategic commercial direction for the NSCLC asset, driving portfolio optimization and lifecycle management. Own enterprise-level launch readiness with governance alignment and flawless pre-launch/launch execution. Lead insight-driven decision-making; convert market intelligence into a compelling brand narrative; use analytics to validate opportunities and maximize ROI. Shape managed markets strategy to deliver pricing, access, and reimbursement solutions. Drive lifecycle management to expand indications and sustain competitive advantage with cross-functional execution. Qualifications
Required: Bachelor’s degree with 10+ years of progressive pharmaceutical experience in marketing or strategy, including exposure to both U.S. and ex-U.S. markets. Required: Proven oncology expertise, including new product planning and successful launch execution. Required: Deep oncology knowledge, market dynamics, brand/franchise management, and effective HCP engagement strategies. Required: 3–5+ years of leadership experience with a track record of managing and developing high-performing teams. Required: Demonstrated P&L ownership and strong financial acumen, including forecasting and resource allocation. Required: Extensive experience in marketing strategy and execution with ability to communicate vision and influence stakeholders and agencies. Required: Strong collaboration skills across countries, functions, and senior leadership to drive asset development and revenue growth. Required: Ability to manage complexity and lead through change with learning agility and adaptability. Required: Strategic decision-making balancing business, financial, and risk considerations to deliver optimal outcomes. Required: Influential leadership, including situations without direct authority, to align stakeholders and drive results. Preferred: MBA and/or PhD. Preferred: Experience in lung cancers.
#J-18808-Ljbffr
Head of Thoracic Cancer, Global Marketing, Oncology Business Unit. As a member of Takeda Oncology, contribute to a bold vision to cure cancer. Report to the Head of Global Marketing Oncology Products, Pipeline and Strategy and collaborate with a cross-functional, global team to drive an asset in the NSCLC space. Responsibilities
Shape and influence global asset strategy through collaboration with R&D and Global Product Leaders, driving the Clinical Development Program and other asset components. Partner with senior leadership across functions to accelerate asset development and deliver on KPI’s and revenue targets. Lead execution of the global asset strategy, ensuring commercial launch readiness and alignment with Oncology objectives. Drive development of the NSCLC Disease Area Strategy and Brand Plan, including branding, financial planning, forecasting, and lifecycle management. Inspire and lead a team of Global Brand Leads to achieve brand success and differentiation. Set strategic commercial direction for the NSCLC asset, driving portfolio optimization and lifecycle management. Own enterprise-level launch readiness with governance alignment and flawless pre-launch/launch execution. Lead insight-driven decision-making; convert market intelligence into a compelling brand narrative; use analytics to validate opportunities and maximize ROI. Shape managed markets strategy to deliver pricing, access, and reimbursement solutions. Drive lifecycle management to expand indications and sustain competitive advantage with cross-functional execution. Qualifications
Required: Bachelor’s degree with 10+ years of progressive pharmaceutical experience in marketing or strategy, including exposure to both U.S. and ex-U.S. markets. Required: Proven oncology expertise, including new product planning and successful launch execution. Required: Deep oncology knowledge, market dynamics, brand/franchise management, and effective HCP engagement strategies. Required: 3–5+ years of leadership experience with a track record of managing and developing high-performing teams. Required: Demonstrated P&L ownership and strong financial acumen, including forecasting and resource allocation. Required: Extensive experience in marketing strategy and execution with ability to communicate vision and influence stakeholders and agencies. Required: Strong collaboration skills across countries, functions, and senior leadership to drive asset development and revenue growth. Required: Ability to manage complexity and lead through change with learning agility and adaptability. Required: Strategic decision-making balancing business, financial, and risk considerations to deliver optimal outcomes. Required: Influential leadership, including situations without direct authority, to align stakeholders and drive results. Preferred: MBA and/or PhD. Preferred: Experience in lung cancers.
#J-18808-Ljbffr